Balasubramanian Kishore, Zuccato Jeffrey A, Kharbat Abdurrahman F, Janssen Christopher, Gonzalez Nancy M, Dunn Ian F
Department of Neurosurgery, University of Oklahoma College of Medicine, Oklahoma City, OK 73104, USA.
Division of Neurosurgery, Texas A&M University College of Medicine, Houston, TX 77030, USA.
Cancers (Basel). 2024 Nov 22;16(23):3915. doi: 10.3390/cancers16233915.
This systematic review consolidates the literature on primary extradural meningiomas (PEMs), a rare subset of meningiomas. We describe the clinical features, management strategies used, and treatment outcomes for published cases. A systematic review was conducted using PRISMA guidelines across multiple databases to 29 July 2024. Inclusion criteria were adult patients with primarily extradural meningioma and where individual patient clinical data were provided. Of 216 studies that met the initial search criteria, 41 satisfied the final inclusion criteria. These 41 studies included 82 patients with 84 total PEMs. The cohort was balanced between sexes with a median age of 46 (range 18-82). Frequent symptoms at initial presentation included pain/headache (46%), weakness (44%), paresthesias (24%), and a palpable superficial mass (23%). The median duration of symptoms to diagnosis was 11 months (range 0.75-120). Surgical resection was the primary treatment approach, achieving a gross total resection in 67% of cases. The majority of lesions were classified as WHO grade 1 (87%). A recurrence was identified during the published follow-up in 11% of cases and a higher WHO grade was expectedly associated with a greater risk of recurrence. The described practice was to use adjuvant radiotherapy in recurrent and high-grade cases. Most cranial lesions were located in the frontal bone, while most spinal lesions affected the cervical spine. Post-treatment symptom improvement or resolution was described in almost all patients at the last follow-up. In comparison to intradural meningiomas, PEMs largely follow a more indolent course with a longer duration of symptoms prior to diagnosis, more benign symptoms, a higher proportion of grade 1 tumors, and favorable outcomes; however, there is a small subset of PEMs with extension outside the cranium and spine that require specific considerations for management.
本系统评价整合了关于原发性硬脑膜外脑膜瘤(PEMs)的文献,这是脑膜瘤中一个罕见的亚型。我们描述了已发表病例的临床特征、使用的管理策略和治疗结果。根据PRISMA指南在多个数据库中进行了系统评价,截至2024年7月29日。纳入标准为患有原发性硬脑膜外脑膜瘤且提供了个体患者临床数据的成年患者。在216项符合初始搜索标准的研究中,41项满足最终纳入标准。这41项研究包括82例患者,共84个PEMs。该队列在性别上均衡,中位年龄为46岁(范围18 - 82岁)。初始表现时常见症状包括疼痛/头痛(46%)、无力(44%)、感觉异常(24%)和可触及的浅表肿块(23%)。症状至诊断的中位持续时间为11个月(范围0.75 - 120个月)。手术切除是主要治疗方法,67%的病例实现了全切。大多数病变被归类为世界卫生组织(WHO)1级(87%)。在已发表的随访期间,11%的病例出现复发,较高的WHO分级预期与更高的复发风险相关。所述做法是在复发和高级别病例中使用辅助放疗。大多数颅骨病变位于额骨,而大多数脊柱病变累及颈椎。在最后一次随访时,几乎所有患者都描述了治疗后症状改善或缓解。与硬脑膜内脑膜瘤相比,PEMs在很大程度上病程更为惰性,诊断前症状持续时间更长,症状更良性,1级肿瘤比例更高,预后良好;然而,有一小部分PEMs超出颅骨和脊柱范围,需要在管理上进行特殊考虑。